Fly-E Group, Inc. Common Stock (FLYE)
Flushing, NY, US
Fly-E Group, Inc. is a company that focuses on the design, installation, and sale of advanced electric personal transportation. Operating primarily under its "Fly E-Bike" brand, the company markets smart electric motorcycles, electric bikes, and electric scooters throughout the United States and Canada. Its diverse product lineup extends to include e-mopeds, e-tricycles, and even traditional bicycles. Beyond the vehicles themselves, Fly-E Group offers a comprehensive range of accessories and replacement parts. This includes protective gear like raincoats, gloves, and knee pads, practical items such as storage baskets, tail boxes, smartphone holders, and backrests, as well as locks and branded clothing. For performance enhancement, the company also supplies upgrade components like specialized wheels, shock absorbers, brake calipers, and carbon fiber body panels. To reach its customer base, Fly-E Group, Inc. also maintains and operates its own retail stores. The company was founded in 2018 and has its headquarters located in Flushing, New York.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +11.05% | +3.08% | +2.03% | -1.47% | -55.13% | -69.77% | -95.86% | -99.58% | -99.58% | -99.58% | -99.58% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Auto - Manufacturers: +8.4%-21.1% Q4'25: -53.3% (vs Q4'24)
-
EPS growth Auto - Manufacturers: +17.3%-379.1% Q4'25: +57.6% (vs Q4'24)
-
FCF margin FCF growth · Auto - Manufacturers: +72.3%-54.8% Q4'25: -237.4% (vs Q4'24)
-
EBIT margin Auto - Manufacturers: +4.6%-17.9% Q4'25: -60.9% (vs Q4'24)
-
ROIC Auto - Manufacturers: +3.7%-16.2% Q4'25: -18.8% (vs Q4'24)
-
Share dilution Auto - Manufacturers: +0.0%+0.0% Q4'25: +563.9% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Auto - Manufacturers: -0.19×15.49× Q4'25: -1.71× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-27 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-26 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-22 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-21 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-20 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-19 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-18 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-15 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-14 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-13 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-12 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-01 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
No beneficial ownership filings recorded.
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 26.2K +26.2K (+100.0%) | 55.1K +55.1K (+100.0%) | 1.61% +1.606 pp | 0.00% +0.000 pp | USD2.10 +0.0% | 1 qtrs NEW |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 12.6K +12.6K (+100.0%) | 26.5K +26.5K (+100.0%) | 0.77% +0.772 pp | 0.00% +0.000 pp | USD2.10 +0.0% | 1 qtrs NEW |
| 3 | VANGUARD FIDUCIARY TRUST CO | 10.7K +10.7K (+100.0%) | 22.5K +22.5K (+100.0%) | 0.66% +0.656 pp | 0.00% +0.000 pp | USD2.10 +0.0% | 1 qtrs NEW |
| 4 | — | 7.1K +7.1K (+100.0%) | 14.8K +14.8K (+100.0%) | 0.43% +0.433 pp | 0.00% +0.000 pp | USD2.10 +0.0% | 1 qtrs NEW |
| 5 | TOWER RESEARCH CAPITAL LLC (TRC) | 2.9K +2.1K (+281.4%) | 6.1K +1.0K (+20.5%) | 0.18% +0.132 pp | 0.00% +0.000 pp | USD3.29 -36.2% | 2 qtrs — |
| 6 | CITIGROUP INC | 1.00 +1.0 (+100.0%) | 2.00 +2.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.00 +5.0% | 1 qtrs NEW |
| 7 | DANSKE BANK A/S | — -15.0 (-100.0%) | — -100.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 8 | SUNBELT SECURITIES, INC. | — -15.0 (-100.0%) | — -100.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 9 | MORGAN STANLEY | — -6.0 (-100.0%) | — -40.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 10 | UBS GROUP AG | — -913.0 (-100.0%) | — -6.1K (-100.0%) | 0.00% -0.056 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 11 | BANK OF AMERICA CORP /DE/ | — -12.0 (-100.0%) | — -80.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 14.0K | 0.05% |
Insider Activity
No insider activity available.
Insider history not available.
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2026 | Zhou Ou Chief Executive Officer | 100.0K | — | — | — | — | — | 100.0K | 0.00% | ↗ |
| 2 | 2025 | Zhou Ou Chief Executive Officer | 100.0K | — | — | — | — | — | 100.0K | 0.00% | ↗ |
| 3 | 2024 | Zhou Ou Chief Executive Officer | 100.0K | — | — | — | — | — | 100.0K | 0.00% | ↗ |
| 4 | 2023 | Zhou Ou Chief Executive Officer | 100.0K | — | — | — | — | — | 100.0K | 0.00% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Zhou Ou | Founder, CEO & Director | 100.0K | male |
| Lisa Fan | Chief Financial Officer & Executive Director | — | female |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FLYE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
